Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Targeted therapies for cancer of the gallbladder.

Thomas MB.

Curr Opin Gastroenterol. 2008 May;24(3):372-6. doi: 10.1097/MOG.0b013e3282f6a7df. Review.

PMID:
18408467
2.

Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy.

Thomas MB.

Crit Rev Oncol Hematol. 2007 Jan;61(1):44-51. Review.

PMID:
17164111
3.

State-of-the-art in the management of locally advanced and metastatic gallbladder cancer.

McNamara MG, Metran-Nascente C, Knox JJ.

Curr Opin Oncol. 2013 Jul;25(4):425-31. doi: 10.1097/CCO.0b013e3283620fd8. Review.

PMID:
23635800
4.

Chemotherapy for gallbladder carcinoma--a surgeon's perspective.

Todoroki T.

Hepatogastroenterology. 2000 Jul-Aug;47(34):948-55. Review.

PMID:
11020856
5.

Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.

Wagner AD, Moehler M.

Curr Opin Oncol. 2009 Jul;21(4):381-5. doi: 10.1097/CCO.0b013e32832c42e0. Review.

PMID:
19412098
6.

Upper gastrointestinal tumors: current status and future perspectives.

Jiang Y, Kimchi ET, Montero AJ, Staveley-O'Carroll KF, Ajani JA.

Expert Rev Anticancer Ther. 2008 Jun;8(6):975-91. doi: 10.1586/14737140.8.6.975. Review.

PMID:
18533807
7.

p53: its alteration and gallbladder cancer.

Rai R, Tewari M, Kumar M, Singh AK, Shukla HS.

Eur J Cancer Prev. 2011 Mar;20(2):77-85. doi: 10.1097/CEJ.0b013e328341e371. Review.

PMID:
21131824
8.

Treatment of patients with advanced soft tissue sarcoma: disappointment or challenge?

Kasper B, Gil T, Awada A.

Curr Opin Oncol. 2007 Jul;19(4):336-40. Review.

PMID:
17545796
9.

Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy.

Bizama C, García P, Espinoza JA, Weber H, Leal P, Nervi B, Roa JC.

Cancer Treat Rev. 2015 Mar;41(3):222-34. doi: 10.1016/j.ctrv.2015.01.003. Epub 2015 Jan 20. Review.

PMID:
25639632
10.

Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies.

Argyriou AA, Antonacopoulou A, Iconomou G, Kalofonos HP.

Crit Rev Oncol Hematol. 2009 Mar;69(3):199-210. doi: 10.1016/j.critrevonc.2008.05.005. Epub 2008 Jul 7. Review.

PMID:
18602834
11.

New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.

Crawford J.

J Natl Compr Canc Netw. 2003 Jan;1 Suppl 1:S78-86. Review.

PMID:
19795580
12.

Identification of cancer stem cells in gallbladder carcinoma: a platform for the discovery of novel therapeutic targets.

Wang X.

Cancer Biol Ther. 2010 Dec 1;10(11):1191-3. Epub 2010 Dec 1. No abstract available.

PMID:
21099373
13.

Molecular advances of brain tumors in radiation oncology.

Noda SE, El-Jawahri A, Patel D, Lautenschlaeger T, Siedow M, Chakravarti A.

Semin Radiat Oncol. 2009 Jul;19(3):171-8. doi: 10.1016/j.semradonc.2009.02.005. Review.

PMID:
19464632
14.

Triple-negative breast cancer.

Stockmans G, Deraedt K, Wildiers H, Moerman P, Paridaens R.

Curr Opin Oncol. 2008 Nov;20(6):614-20. doi: 10.1097/CCO.0b013e328312efba. Review.

PMID:
18841042
15.

Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.

Wallerand H, Reiter RR, Ravaud A.

Curr Opin Urol. 2008 Sep;18(5):524-32. doi: 10.1097/MOU.0b013e3283097889. Review.

PMID:
18670279
16.

Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.

Alvarez H, Corvalan A, Roa JC, Argani P, Murillo F, Edwards J, Beaty R, Feldmann G, Hong SM, Mullendore M, Roa I, Ibañez L, Pimentel F, Diaz A, Riggins GJ, Maitra A.

Clin Cancer Res. 2008 May 1;14(9):2631-8. doi: 10.1158/1078-0432.CCR-07-1991.

17.

Experimental therapies in Ewing's sarcoma.

Windsor R, Strauss S, Seddon B, Whelan J.

Expert Opin Investig Drugs. 2009 Feb;18(2):143-59. doi: 10.1517/13543780802715784 . Review.

PMID:
19236262
18.

Targeted therapies in lung cancer.

Pirker R, Filipits M.

Curr Pharm Des. 2009;15(2):188-206.

PMID:
19149612
19.
20.

Activation of growth factor receptors in esophageal cancer--implications for therapy.

Ekman S, Bergqvist M, Heldin CH, Lennartsson J.

Oncologist. 2007 Oct;12(10):1165-77. Review.

Supplemental Content

Support Center